Addition of Spironolactone to Ambrisentan May Be a Novel Treatment Strategy to Improve Outcome in Patients with PAH

Maria Vinall

doi:10.1177/155989771304007

Maria Vinall

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
View author's works on this site

Bradley Maron

Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
View author's works on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint
Figure 1.
Change From Baseline in the 6-Minute Walk Distance
Reproduced with permission from B Maron, MD.

PreviousNext

Tools

Download PDF

View Full Page PDF

Citation Tools

Addition of Spironolactone to Ambrisentan May Be a Novel Treatment Strategy to Improve Outcome in Patients with PAH

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Thank you for your interest in spreading the word on MD Conference Express.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Addition of Spironolactone to Ambrisentan May Be a Novel Treatment Strategy to Improve Outcome in Patients with PAH

Message Subject (Your Name) has sent you a message from MD Conference Express

Message Body (Your Name) thought you would like to see the MD Conference Express web site.

Your Personal Message